Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing April 29, 2025 Related Posts Are We in a Recession? Predictions, Signs and Strategies April 29, 2025 What is the VIX Index? April 29, 2025 Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors April 29, 2025